Back to search
FDAFDA · Food and drugs·Recall number Z-1903-2024

Trevo ProVue, Catalog: 90184

Published June 5, 2024 · Recall initiated: April 23, 2024

Summary

FDA records medical device Class II recall Z-1903-2024, published June 5, 2024 and initiated April 23, 2024. Recalling firm: Stryker Neurovascular; Status: Ongoing; Reported quantity: 280; Lot: Catalog: 90184, UDI-DI: 00815742001846, Lot: 118117, 118420, 118833. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Stryker Neurovascular
Distributor
Worldwide - US Nationwide distribution including in the states of MN, PA, IL, AK, NY, CA, MI, WI, TX, AZ, FL, KY, MA, IN, NE, MT, CT, NJ, TN, VA, AL, CO, DE, OH, UT, NC, ME, GA, SC, GU, WA, MO, OR, DC, OK, LA, MD, ID, NH, SD, NV, RI, ND, HI, MS, AR, IA, NM, VT, KS and the countries of Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, SAR China, Hungary, India, Ireland, Israel, Italy, Japan, Korea (South), Lithuania, Luxembourg, Netherlands, Northern Ireland, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan, Republic of China, Thailand, Turkey, United Arab Emirates, United Kingdom.
Lot
Catalog: 90184, UDI-DI: 00815742001846, Lot: 118117, 118420, 118833
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Trevo ProVue, Catalog: 90184 recalled?

Yes. FDA published recall Z-1903-2024 on June 5, 2024. Reported hazard: Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.

What should I do if I have this product?

Voluntary: Firm initiated · Letter